{
    "Trade/Device Name(s)": [
        "Nova StatSensor Creatinine Hospital Meter System"
    ],
    "Submitter Information": "Nova Biomedical Corporation",
    "510(k) Number": "K171059",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070068"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGL"
    ],
    "Summary Letter Date": "April 26, 2017",
    "Summary Letter Received Date": "April 27, 2017",
    "Submission Date": "May 26, 2017",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood",
        "Arterial whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Nova StatSensor Creatinine Hospital Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme",
        "Amperometric",
        "Electrochemical biosensor"
    ],
    "Methodologies": [
        "Electrochemical biosensor testing"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Accessory",
        "Control",
        "Linearity Solution",
        "Docking/Charging Station"
    ],
    "Document Summary": "FDA 510(k) summary for Nova StatSensor Creatinine Hospital Meter System for measurement of creatinine in whole blood using enzymatic electrochemical biosensor technology.",
    "Indications for Use Summary": "Intended for in vitro diagnostic use by healthcare professionals and for Point-Of-Care usage for quantitative measurement of creatinine in capillary, venous, and arterial whole blood; used in diagnosis and treatment of renal diseases and monitoring renal dialysis; not for use in neonates.",
    "fda_folder": "Clinical Chemistry"
}